Serotonin-immune Interactions in Major Depression: Lower Serum Tryptophan As a Marker of an Immune-inflammatory Response

Overview

Journal Eur Arch Psychiatry Clin Neurosci

Specialties Neurology
Psychiatry

Date 1997 Jan 1

PMID 9224908

Citations 23

Authors

M Maes

R Verkerk

E Vandoolaeghe

F van Hunsel

H Neels

A Wauters

P Demedts

S Scharpe

Affiliations

Soon will be listed here.

Abstract

Serum total tryptophan and the five competing amino acids (CAA), i.e., valine, leucine, tyrosine, phenylalanine, and isoleucine were determined in 35 major depressed subjects of whom 27 with treatment resistant depression (TRD), and 15 normal controls. Twenty-five of the depressed subjects had repeated measurements of the amino acids both before and after antidepressive treatment. The following immune-inflammatory variables were assayed in the above subjects: serum zinc (Zn), total serum protein (TSP), albumin (Alb), transferrin (Tf), iron (Fe), high-density lipoprotein cholesterol (HDL-C), number of peripheral blood leukocytes, and the CD4+/CD8+ T cell (T-helper/T-suppressor) ratio. Serum tryptophan and the tryptophan/CAA ratio were significantly lower in major depressed subjects than in normal controls. The tryptophan/CAA ratio was significantly lower in patients with TRD than in patients without TRD and normal controls. There were no significant alterations in any of the amino acids upon successful therapy. There were significant correlations between serum tryptophan and serum Zn, TSP, Alb, Tf, Fe, and HDL-C (all positive), and number of leukocytes and the CD4+/CD8+ T-cell ratio (all negative). The tryptophan/CAA ratio was significantly and negatively related to the number of leukocytes and the CD4+/CD8+ T-cell ratio. The results suggest that (a) TRD is characterized by lower availability of serum tryptophan; (b) the availability of tryptophan may remain decreased despite clinical recovery; and (c) the lower availability of tryptophan is probably a marker of the immune-inflammatory response during major depression.

Citing Articles

A study investigating how the albumin-globulin ratio relates to depression risk within U.S. adults: a cross-sectional analysis.

Xu Q, Wang J, Li H, Chen X Front Nutr. 2024; 11:1453044.

PMID: 39421614 PMC: 11484099. DOI: 10.3389/fnut.2024.1453044.

The Tryptophan Index Is Associated with Risk of Ischemic Stroke: A Community-Based Nested Case-Control Study.

Liu D, Hong Y, Chen Z, Ma Y, Xia S, Gu S Nutrients. 2024; 16(11).

PMID: 38892478 PMC: 11174068. DOI: 10.3390/nu16111544.

Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders.

Li Y, Wang L, Huang J, Zhang P, Zhou Y, Tong J Front Psychiatry. 2024; 15:1357293.

PMID: 38680780 PMC: 11046465. DOI: 10.3389/fpsyt.2024.1357293.

Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer.

Zhan D, Wang X, Zheng Y, Wang S, Yang B, Pan B Front Oncol. 2023; 13:1147189.

PMID: 37795441 PMC: 10546427. DOI: 10.3389/fonc.2023.1147189.

Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID.

Al-Hakeim H, Abed A, Moustafa S, Almulla A, Maes M Front Mol Neurosci. 2023; 16:1194769.

PMID: 37333619 PMC: 10272345. DOI: 10.3389/fnmol.2023.1194769.

References

Lucca A, Lucini V, Catalano M, Alfano M, Smeraldi E . Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor. Neuropsychobiology. 1994; 29(3):108-11. DOI: 10.1159/000119071. View

Maes M, Meltzer H, Cosyns P, Schotte C . Evidence for the existence of major depression with and without anxiety features. Psychopathology. 1994; 27(1-2):1-13. DOI: 10.1159/000284842. View

Heyes M, Brew B, Saito K, Quearry B, Price R, Lee K . Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J Neuroimmunol. 1992; 40(1):71-80. DOI: 10.1016/0165-5728(92)90214-6. View

Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H . Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr Scand. 1996; 94(3):198-204. DOI: 10.1111/j.1600-0447.1996.tb09849.x. View

Smith S, Pihl R, Young S, Ervin F . A test of possible cognitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males. Psychopharmacology (Berl). 1987; 91(4):451-7. DOI: 10.1007/BF00216010. View

Song C, Dinan T, Leonard B . Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord. 1994; 30(4):283-8. DOI: 10.1016/0165-0327(94)90135-x. View

Maes M, Scharpe S, Meltzer H, Okayli G, Bosmans E, DHondt P . Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Res. 1994; 54(2):143-60. DOI: 10.1016/0165-1781(94)90003-5. View

Maes M, Van de Vyvere J, Vandoolaeghe E, Bril T, Demedts P, Wauters A . Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process. J Affect Disord. 1996; 40(1-2):23-33. DOI: 10.1016/0165-0327(96)00038-9. View

Holmes E, Russell P, Kinzler G, Reckard C, Flanigan R, K D Thompson . Oxidative tryptophan metabolism in renal allograft recipients: increased kynurenine synthesis is associated with inflammation and OKT3 therapy. Cytokine. 1992; 4(3):205-13. DOI: 10.1016/1043-4666(92)90057-x. View

10.

Deakin J, Pennell I, Upadhyaya A, Lofthouse R . A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology (Berl). 1990; 101(1):85-92. DOI: 10.1007/BF02253723. View

11.

Delgado P, Charney D, Price L, Landis H, Heninger G . Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sci. 1989; 45(24):2323-32. DOI: 10.1016/0024-3205(89)90114-8. View

12.

Maes M, Meltzer H, Scharpe S, Bosmans E, Suy E, De Meester I . Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Res. 1993; 49(2):151-65. DOI: 10.1016/0165-1781(93)90102-m. View

13.

Maes M, Meltzer H, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R . Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord. 1995; 34(4):301-9. DOI: 10.1016/0165-0327(95)00028-l. View

14.

PEREZ-CRUET J, Chase T, Murphy D . Dietary regulation of brain tryptophan metabolism by plasma ratio of free tryptophan and neutral amino acids in humans. Nature. 1974; 248(5450):693-5. DOI: 10.1038/248693a0. View

15.

Russ M, Ackerman S, Banay-Schwartz M, Shindledecker R, Smith G . Plasma tryptophan to large neutral amino acid ratios in depressed and normal subjects. J Affect Disord. 1990; 19(1):9-14. DOI: 10.1016/0165-0327(90)90003-q. View

16.

Young S, Smith S, Pihl R, Ervin F . Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berl). 1985; 87(2):173-7. DOI: 10.1007/BF00431803. View

17.

Heninger G, Delgado P, Charney D, Price L, Aghajanian G . Tryptophan-deficient diet and amino acid drink deplete plasma tryptophan and induce a relapse of depression in susceptible patients. J Chem Neuroanat. 1992; 5(4):347-8. DOI: 10.1016/0891-0618(92)90025-l. View

18.

Moller S . Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments. Acta Psychiatr Scand Suppl. 1985; 325:3-31. View

19.

Maes M, Wauters A, Verkerk R, Demedts P, Neels H, Van Gastel A . Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism. Neuropsychopharmacology. 1996; 15(3):243-51. DOI: 10.1016/0893-133X(95)00181-C. View

20.

Ashcroft G, Blackburn I, Eccleston D, GLEN A, Hartley W, Kinloch N . Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness. Psychol Med. 1973; 3(3):319-25. DOI: 10.1017/s0033291700049606. View